Granahan Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Granahan Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-44,625	Closed	-$1.85M	–	202
2020 Q3	$1.85M	Sell	44,625 -5,717	-11%	-$263K	0.06%	159
2020 Q2	$2.41M	Buy	50,342 +231	+0.5%	+$17.8K	0.09%	145
2020 Q1	$3.15M	Buy	50,111 +15	+0%	+$1.35K	0.17%	109
2019 Q4	$6.21M	Sell	50,096 -1,872	-4%	-$168K	0.29%	82
2019 Q3	$3.45M	Buy	51,968 +3,663	+8%	+$246K	0.19%	106
2019 Q2	$3.84M	Sell	48,305 -4,435	-8%	-$397K	0.19%	102
2019 Q1	$5.9M	Buy	+52,740	New	+$5.76M	0.32%	85

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Granahan Investment Management's ICPT Position: Q4 2020 in Review

Granahan Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 44,625 shares — an estimated $1.85M sold.

Granahan Investment Management first reported a position in ICPT in Q1 2019 and held it in 7 quarters. The position peaked at $6.21M in Q4 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

Granahan Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Granahan Investment Management sold 44,625 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.85M.
Granahan Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2019 and held it in 7 quarters.
Granahan Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $6.21M in Q4 2019.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.